Access cutting-edge pediatric solid tumors treatment through this clinical trial at a research site in Birmingham. Study-provided care at no cost to qualified participants.
Access pediatric solid tumors specialists in Birmingham at no cost
This study follows strict safety protocols and ethical guidelines
All study-related pediatric solid tumors treatment provided free
This study will expand the types of pediatric cancers being evaluated for response to cabozantinib. The current COG study is restricted to Ewing sarcoma, osteosarcoma, rhabdomyosarcoma, Wilms tumor, and a handful of uncommon tumors. The proposed study will extend this evaluation to tumors that have been shown to either express known targets of cabozantinib or with preclinical evidence of efficacy, including specifically neuroblastomas. These tumors have high morbidity and mortality, particularly
Sponsor: Nationwide Children's Hospital
Check if you qualify for this pediatric solid tumors clinical trial in Birmingham, AL
If you're searching for pediatric solid tumors treatment options in Birmingham, AL, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Birmingham research site is actively enrolling participants for this clinical trial. You'll receive care from experienced pediatric solid tumors specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.